Ignite Creation Date:
2025-12-24 @ 1:33 PM
Ignite Modification Date:
2026-01-24 @ 5:53 AM
Study NCT ID:
NCT00972595
Status:
COMPLETED
Last Update Posted:
2015-08-19
First Post:
2009-09-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0869-106
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None